Results 131 to 140 of about 16,479 (221)

Clinical Practice of Multidisciplinary Team-Guided Comprehensive Management for Pediatric Patients with Fabry Disease: A Single-Center Case Series. [PDF]

J Multidiscip Healthc
Liu Y, Liu X, Yang M, Wang Q, Xu W, Zeng J, Han T, Mao H, Qian S.   +8 more
europepmc   +1 more source

Analysis of ASMs and male infertility using the FDA adverse event reporting system (FAERS). [PDF]

Front Public Health
An K, Xu J, Xi Y, Cao X, Wang J, Hu X, Liang X.   +6 more
europepmc   +1 more source

Correction: Prediction of personalized antiseizure medications response based on clinical signatures in epilepsy. [PDF]

Sci Rep
Park KI, Shin Y, Hwang S, Kim YJ, Lee SB, Son H, Moon J, Lee ST, Jung KH, Chu K, Jung KY, Kim YG, Lee SK.   +12 more
europepmc   +1 more source

Unravelling the Mystery of Vestibular Paroxysmia: A Case Series. [PDF]

Cureus
Manchikanti V, Kulakarni P, Bapat M, Jose B.   +3 more
europepmc   +1 more source

Antiepileptic Drug-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Case Series. [PDF]

Cureus
Mohaideen M, Meera M, Sekar I.
europepmc   +1 more source

Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus [PDF]

, 2014

core   +1 more source

American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy. [PDF]

Epilepsy Curr
Freedman D, Babatunde I, Morgan RL, Abu-Sawwa R, Albert D, Behbahani M, Chapman K, Fecske E, Gaillard WD, Jones M, Meskis MA, Myers LS, Nye K, Oluigbo C, Pfeifer HH, Shellhaas RA, Thompson L, Weiner HL, Wusthoff CJ, Yozawitz E.   +19 more
europepmc   +1 more source

Correction: Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10‑Monohydroxy Derivative to Inform Dosing in Children with Obesity. [PDF]

Clin Pharmacokinet
Sinha J, Zimmerman K, Balevic SJ, Hornik C, Muller WJ, Rathore M, Meyer M, Finkelstein Y, Al-Uzri A, Lakhotia A, Goldstein S, Chen JY, Anand R, Gonzalez D, Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee.   +14 more
europepmc   +1 more source

Drug-resistant Epilepsy: Which Drugs are Substrates of P-glycoprotein and Which are Not? [PDF]

Curr Neuropharmacol
Aylón Val J, Hernando-Requejo V.
europepmc   +1 more source

<i>KCNQ2</i> Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients. [PDF]

Neurol Genet
Li Y, Li J, Li L, Zhang H, Sun X.
europepmc   +1 more source